Vasoactive intestinal peptide signaling axis in human leukemia

doi:10.4331/wjbc.v2.i6.146

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7920)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

571

HTML

6437

Figures (1-7)

650

Tables (1-1)

262

Sum=7920

Jun 26, 2011 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Biol Chem. Jun 26, 2011; 2(6): 146-160
Published online Jun 26, 2011. doi: 10.4331/wjbc.v2.i6.146

Full Size Figure Download Figure

Figure 6 Ikaros engagement of the vasoactive intestinal peptide receptor 1 promoter in primary and T cell lines. Schematic representation of electrophoretic mobility shift assays and chromatin immunoprecipitation assays data comparing Ikaros engagement to the vasoactive intestinal peptide receptor (VPAC)1 promoter in primary CD4 T cells compared to the human lymphoblastic T cell line, Hut-78 cells. Top panels represent the expression profile for Ikaros in resting cells, and the bottom panels represent activated T cells.

Citation: Dorsam GP, Benton K, Failing J, Batra S. Vasoactive intestinal peptide signaling axis in human leukemia. World J Biol Chem 2011; 2(6): 146-160
URL: https://www.wjgnet.com/1949-8454/full/v2/i6/146.htm
DOI: https://dx.doi.org/10.4331/wjbc.v2.i6.146